Lopinavir/ritonavir can cause delayed anaphylactic shock, requiring prompt recognition and treatment.
Answers are grounded in this paper and cite their sources.
Case of lopinavir/ritonavir anaphylactic shock during PEP warrants vigilance; leaves open incidence and risk factors in exposed healthcare workers.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: